Skip Navigation

Brain 2005 128(8):1745-1746; doi:10.1093/brain/awh592
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Darnell, R. B.
Right arrow Articles by Posner, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darnell, R. B.
Right arrow Articles by Posner, J. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Scientific Commentary

A new cause of limbic encephalopathy

The first 10% of the full text of this article appears below.

The spectrum of antibody-associated encephalopathy seems ever increasing. In 2004 Vincent et al. described, in this journal, a series of patients with a reversible limbic encephalopathy associated with antibodies against the voltage-gated potassium channels (VGKC-Ab). In this issue, Ances et al. (2005)Go have described yet another cause of limbic encephalopathy, this time a paraneoplastic disorder. Furthermore, they have suggested a classification to aid the physician in diagnosis and treatment and allow one to predict prognosis.

Beau Ances and colleagues describe seven patients with the subacute onset of a limbic encephalopathy. The . . . [Full Text of this Article]

Robert B. Darnell1 and Jerome B. Posner2

1 The Rockefeller University, 1230 York Avenue and 2 Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, USA

E-mail: posnerj@mskcc.org


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BMJ Case ReportsHome page
H. Shimazaki, Y. Ando, I. Nakano, and J. Dalmau
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus
BMJ Case Reports, January 22, 2009; 2009(jan21_1): bcr0720080509 - bcr0720080509.
[Abstract] [Full Text]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
L Bataller, K A Kleopa, G F Wu, J E Rossi, M R Rosenfeld, and J Dalmau
Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes
J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 381 - 385.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
H Shimazaki, Y Ando, I Nakano, and J Dalmau
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 324 - 325.
[Full Text] [PDF]

Home page
 PNHome page
J. M Schott
Limbic encephalitis: a clinician's guide
Practical Neurology, June 1, 2006; 6(3): 143 - 153.
[Full Text] [PDF]